People: CNH Industrial NV (CNHI.MI)

CNHI.MI on Milan Stock Exchange

15 Oct 2019
Change (% chg)

€0.13 (+1.39%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Theurillat, Jacques 

Mr. Jacques Theurillat serves as Non-Executive Independent Director at CNH Industrial NV. He is Chairperson of the Audit Committee of the Company. Mr. Theurillat was a Director of CNH from April 7, 2006 until the integration of the company into CNH Industrial. Since May, 2008, Mr. Theurillat has served as Partner of Ares Life Sciences, a private equity fund whose objective is to build a portfolio in life sciences. Mr. Theurillat served as the Serono SA Deputy CEO until December 2006. In addition to his role as Deputy CEO, he was appointed Senior Executive Vice President, Strategic Corporate Development in May 2006 and was responsible for developing the company’s global strategy and pursuing Serono’s acquisition and in-licensing initiatives. From 2002 to 2006, Mr. Theurillat served as Serono’s President of European and International Sales & Marketing. In this position he was responsible for Serono’s commercial operations in Europe, IBO, Asia-Pacific, Oceania/Japan, Latin America and Canada. He became a Board member in May 2000. From 1996 to 2002, he was Chief Financial Officer. He previously served as Managing Director of the Istituto Farmacologico Serono in Rome, where he started in 1994. In 1993, he was appointed Vice President Taxes and Financial Planning for Serono. In 1990-1993, Mr. Theurillat worked outside Serono, running his own law and tax firm. Before that, he was Serono’s Corporate Tax Director, a post to which he was appointed in 1988. He first joined Serono in 1987 as a Corporate Lawyer working on projects such as the company’s initial public offering. Mr. Theurillat is a Swiss barrister and holds Bachelor of Law degrees from both Madrid University and Geneva University. He also holds a Swiss Federal Diploma (Tax Expert) and has a Master’s degree in Finance.

Basic Compensation

Total Annual Compensation, EUR 160,000
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR 20,574
Fiscal Year Total, EUR 180,574

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --